What do a prominent physiologist and two-time survivor of pancreatic cancer and a world-renowned researcher whose landmark discoveries on aspirin, drug therapies of proven benefit and therapeutic lifestyle changes that have ...
Aug 26, 2015
0
29
Cancer cases and deaths are expected to double in Africa during the next two decades, according to findings from a new study by Penn State College of Medicine researchers. The study also reveals that the region lacks sufficient ...
Jun 14, 2022
0
46
Your risk of breast cancer increases with age, especially after menopause. Around eight out of 10 breast cancer cases happen in women over 50.
Oct 12, 2023
0
2
In a review article recently published in the journal Clinical and Translational Medicine, researchers from Boston University School of Medicine (BUSM) shed new light on the underlying processes of tumor metastasis and highlight ...
Mar 6, 2015
0
87
Applying the same solution to different problems is a common mistake, not only among humans but also in our immune system. Flooding a wound with inflammation-causing white blood cells can be helpful for fighting infection, ...
May 8, 2023
0
17
Moffitt Cancer Center researchers suggest secondary cancers seen in melanoma patients who are being treated for a BRAF gene mutation may require new strategies, such as enhanced surveillance and combining BRAF-inhibitor therapy ...
Aug 14, 2013
0
0
Genetics clearly plays a role in cancer development and progression, but the reason that a certain mutation leads to one cancer and not another is less clear. Furthermore, no links have been found between any cancer and a ...
Aug 2, 2012
0
0
(HealthDay)—Breast cancer survivor Jessica Sidener is adamant that her illness brought real benefits to her life.
Apr 5, 2019
0
0
For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes. ...
Mar 10, 2021
0
12
A one-two punch of changing gene expression, then deploying immune checkpoint inhibitors, shows promise in battling one of the most treatment-resistant types of cancer in preclinical models, according to a new publication ...
Sep 30, 2020
0
8
